Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R López Castro

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Archivos Latinoamericanos De Nutricion|September 1, 1982
Protein requirements of young adult men fed a Mexican rural dietH Bourges, B R López-Castro
Revista Cubana De Enfermeria|January 1, 1989
[A developmental study of low birth weight infants in 1986]M R González Delgado, D R López Castro, A M Longa Monteagudo
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|July 27, 2012
Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genesM Cuadros, C Cano, F J López, et al.
Neurologia|March 29, 2020
[SMART syndrome]J M Martín Guerra, R López Castro, M Martín Asenjo, et al.
Archivos De La Sociedad Espanola De Oftalmologia|June 7, 2021
Intraocular metastasis as a systemic presentation of neuroendocrine differentiation of prostate carcinomaF J Valentín Bravo, M A Saornil Álvarez, C García Álvarez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2021
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)E Nadal, J Bosch-Barrera, S Cedrés, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2020
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trialS Popat, A Curioni-Fontecedro, U Dafni, et al.
Cancer Treatment and Research Communications|April 15, 2025
Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1M Sereno, A Collazo-Lorduy, Y Garitaonaindia, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Archivos Latinoamericanos De Nutricion|September 1, 1982
Protein requirements of young adult men fed a Mexican rural dietH Bourges, B R López-Castro
Revista Cubana De Enfermeria|January 1, 1989
[A developmental study of low birth weight infants in 1986]M R González Delgado, D R López Castro, A M Longa Monteagudo
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|July 27, 2012
Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genesM Cuadros, C Cano, F J López, et al.
Neurologia|March 29, 2020
[SMART syndrome]J M Martín Guerra, R López Castro, M Martín Asenjo, et al.
Archivos De La Sociedad Espanola De Oftalmologia|June 7, 2021
Intraocular metastasis as a systemic presentation of neuroendocrine differentiation of prostate carcinomaF J Valentín Bravo, M A Saornil Álvarez, C García Álvarez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2021
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)E Nadal, J Bosch-Barrera, S Cedrés, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2020
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trialS Popat, A Curioni-Fontecedro, U Dafni, et al.
Cancer Treatment and Research Communications|April 15, 2025
Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1M Sereno, A Collazo-Lorduy, Y Garitaonaindia, et al.
Pageof 1